Emmy G. Fleuren
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
High-throughput 3D engineered paediatric tumour models for precision medicine.
Journal: Molecular systems biology
Published: August 13, 2025
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
One Size Does Not Fit All: Precision Combinations for FGFR4-driven Cancers.
Journal: Frontiers in bioscience (Landmark edition)
Published: June 18, 2025
Precision-guided treatment in high-risk pediatric cancers.
Journal: Nature medicine
Published: September 21, 2023
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
Journal: Nature communications
Published: April 05, 2023
Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers.
Journal: Oncogene
Published: December 21, 2022
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma.
Journal: Frontiers in oncology
Published: August 06, 2022
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors.
Journal: Biomedicines
Published: November 08, 2021
Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: March 07, 2021
Last Updated: 09/26/2026